In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

The price of Takeda Pharmaceutical Co ADR (NYSE: TAK) closed at $14.8 in the last session, up 0.20% from day before closing price of $14.77. In other words, the price has increased by $0.20 from its previous closing price. On the day, 2.43 million shares were traded. TAK stock price reached its highest trading level at $14.8153 during the session, while it also had its lowest trading level at $14.69.

Ratios:

We take a closer look at TAK’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.08 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 8.55. For the most recent quarter (mrq), Quick Ratio is recorded 0.59 and its Current Ratio is at 1.16. In the meantime, Its Debt-to-Equity ratio is 0.66 whereas as Long-Term Debt/Eq ratio is at 0.60.

On March 16, 2023, BofA Securities Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $20.

Cowen Upgraded its Market Perform to Outperform on July 19, 2022, whereas the target price for the stock was revised from $21 to $24.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Jul 09 ’25 when Thomas Wozniewski bought 6,136 shares for $15.42 per share.

Teresa Marie Bitetti bought 52,649 shares of TAK for $811,848 on Jul 09 ’25. On Jul 09 ’25, another insider, Ramona A Sequeira, who serves as the President, Global Portfolio Di of the company, bought 102,972 shares for $15.42 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TAK now has a Market Capitalization of 46741655552 and an Enterprise Value of 4715090804736. As of this moment, Takeda’s Price-to-Earnings (P/E) ratio for their current fiscal year is 50.05, and their Forward P/E ratio for the next fiscal year is 22.75. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 1.12. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.54 while its Price-to-Book (P/B) ratio in mrq is 0.97. Its current Enterprise Value per Revenue stands at 1.052 whereas that against EBITDA is 3.868.

Stock Price History:

The Beta on a monthly basis for TAK is 0.26, which has changed by 0.020689607 over the last 52 weeks, in comparison to a change of 0.16461086 over the same period for the S&P500. Over the past 52 weeks, TAK has reached a high of $15.53, while it has fallen to a 52-week low of $12.80. The 50-Day Moving Average of the stock is 0.17%, while the 200-Day Moving Average is calculated to be 3.94%.

Shares Statistics:

According to the various share statistics, TAK traded on average about 3.26M shares per day over the past 3-months and 4422890 shares per day over the past 10 days. A total of 3.12B shares are outstanding, with a floating share count of 3.12B. Insiders hold about 0.00% of the company’s shares, while institutions hold 2.35% stake in the company. Shares short for TAK as of 1753920000 were 8223830 with a Short Ratio of 2.53, compared to 1751241600 on 5087639. Therefore, it implies a Short% of Shares Outstanding of 8223830 and a Short% of Float of 0.26.

Dividends & Splits

The forward annual dividend rate for TAK is 0.33, which was 196.0 in the trailing 12 months. Against a Trailing Annual Dividend Yield of 13.270142The stock’s 5-year Average Dividend Yield is 4.69.